We are live on ! Find out more
MS

Marshall & Sullivan Portfolio holdings

AUM $216M
1-Year Est. Return 12.97%
This Fund
S&P 500
This Quarter Est. Return
+1.59%
1 Year Est. Return
+12.97%
3 Year Est. Return
+82%
5 Year Est. Return
+98.09%
10 Year Est. Return
+292.06%
AUM
$77.6M
AUM Growth
-$1.01M
Cap. Flow
-$1.22M
Cap. Flow %
-1.57%
Top 10 Hldgs %
45.21%
Holding
65
New
1
Increased
2
Reduced
32
Closed
9

Top Buys

Rank Stock Value
1
SPNC
Spectranetics Corp
SPNC
+$17.6K
2
SRCL
Stericycle Inc
SRCL
+$8.24K
3
AAPL icon
Apple
AAPL
+$5.96K

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$328K
2
SBUX icon
Starbucks
SBUX
+$114K
3
DHR icon
Danaher
DHR
+$53.4K
4
SYK icon
Stryker
SYK
+$49.2K
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$49K

Sector Composition

Rank Sector Weight
1 Healthcare 32.84%
2 Consumer Staples 18.06%
3 Technology 16.39%
4 Consumer Discretionary 12.6%
5 Industrials 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMZN icon
51
Amazon
AMZN
$2.44T
$7K 0.01%
200
– –
MNKD icon
52
MannKind Corp
MNKD
$1.19B
$7K 0.01%
1,289
– –
HPE icon
53
Hewlett Packard
HPE
$58.8B
$4K 0.01%
358
– –
HPQ icon
54
HP
HPQ
$26B
$3K ﹤0.01%
208
– –
QMCO icon
55
Quantum Corp
QMCO
$411M
$2K ﹤0.01%
25
-1
-4% -$73
EQNR icon
56
Equinor
EQNR
$97.3B
– –
-875
Closed -$13K
IONS icon
57
Ionis Pharmaceuticals
IONS
$8.93B
– –
-100
Closed -$4K
MRK icon
58
Merck
MRK
$322B
– –
-210
Closed -$11K
PFE icon
59
Pfizer
PFE
$143B
– –
-128
Closed -$4K
REGN icon
60
Regeneron Pharmaceuticals
REGN
$72.9B
– –
-100
Closed -$49K
VANI icon
61
Vivani Medical
VANI
$109M
– –
-10
Closed -$2K
VSTM icon
62
Verastem
VSTM
$528M
– –
-42
Closed -$3K
JUNO
63
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-125
Closed -$5K
WFM
64
DELISTED
Whole Foods Market Inc
WFM
– –
-100
Closed -$3K
1 2
3

Similar funds

DSN
D. Scott Neal Lexington, Kentucky $216M AUM 33.28% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
FFAM
Forge First Asset Management Toronto, Ontario, Canada $218M AUM 29.22% 1-Year Est. Return
NWM
Napa Wealth Management Napa, California $213M AUM 25.01% 1-Year Est. Return
LA
Lindenwold Advisors Reading, Pennsylvania $212M AUM 13.02% 1-Year Est. Return
APC
Asset Planning Corporation Knoxville, Tennessee $211M AUM 7.33% 1-Year Est. Return
WTFG
Wells Trecaso Financial Group Akron, Ohio $210M AUM 21.47% 1-Year Est. Return
SNWA
Siligmueller & Norvid Wealth Advisors Glen Ellyn, Illinois $222M AUM 10.94% 1-Year Est. Return

Marshall & Sullivan's Q2 2016 Portfolio in Review

As of Q2 2016, Marshall & Sullivan held 65 positions worth $77.6M, down 1.3% from $78.6M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Marshall & Sullivan's Q2 2016 filing shows 1 new, 2 increased, 32 reduced and 9 closed positions. Its largest new stake was Spectranetics Corp: 1,000 shares worth $18K. The largest sale was Alphabet (Google) Class C, an estimated $328K.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 31% a quarter earlier, followed by Consumer Staples and Technology.

  • Marshall & Sullivan's largest Q2 2016 buy was Spectranetics Corp: 1,000 shares worth $18K.
  • Marshall & Sullivan added most to Stericycle Inc in Q2 2016, an estimated $8.24K increase.
  • Marshall & Sullivan's biggest Q2 2016 reduction was Alphabet (Google) Class C, cutting an estimated $328K.
  • Marshall & Sullivan fully exited Regeneron Pharmaceuticals in Q2 2016, selling an estimated $49K.
  • Marshall & Sullivan's ten largest holdings make up 45% of its $77.6M portfolio in Q2 2016.
  • Marshall & Sullivan opened 1 new position and closed 9 in Q2 2016.
  • Marshall & Sullivan's portfolio value fell 1.3% quarter-over-quarter to $77.6M.

Based on Marshall & Sullivan's 13F filing for Q2 2016, filed 12 Aug 2016.